IGF::OT::IGF Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorcer. NIDA Ref. No. N01DA-16-8926; POP: 09/18/2016 - 09/17/2021.

Murty Pharmaceuticals, Inc., Lexington KY

Investigators

Abstract

The purpose of this contract is to carry out the development and manufacture of pharmaceutical preparations to be used in the medications development program for addiction treatment at the National Institute on Drug Abuse (NIDA).